Extended Data Fig. 4: DTI measurements.
From: Dual-vector rAAVrh8 gene therapy for GM2 gangliosidosis: a phase 1/2 trial

DTI measurements of the lentiform nucleus are shown for the infantile patients (Patients 001, 004, 007, 008, 010, 011).
From: Dual-vector rAAVrh8 gene therapy for GM2 gangliosidosis: a phase 1/2 trial
DTI measurements of the lentiform nucleus are shown for the infantile patients (Patients 001, 004, 007, 008, 010, 011).